Cipla schedules analyst meetings in Gurgaon and Mumbai
- Cipla holds analyst meeting at Jefferies India Forum on September 17
- Company attends Kotak Healthcare Conference on September 18
- Both engagements are scheduled as in-person events

*this image is generated using AI for illustrative purposes only.
Cipla Limited has announced a schedule of meetings with analysts and institutional investors for mid-September 2026. The company will participate in two in-person events across Gurgaon and Mumbai.
The engagements are scheduled as follows:
| Date | Conference Name | Venue | Type |
|---|---|---|---|
| September 17, 2026 | Jefferies India Forum Conference | Gurgaon | In person |
| September 18, 2026 | Kotak Healthcare Conference | Mumbai | In person |
The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rajendra Chopra, Company Secretary, signed the intimation on August 27, 2026.
The schedule is subject to change due to unforeseen circumstances involving the investor or the company.
Historical Stock Returns for Cipla
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.25% | -1.01% | +1.00% | +5.59% | -9.89% | +54.08% |
What specific strategic updates or financial guidance is Cipla likely to present at these September 2026 conferences given the current market sentiment?
How might the outcomes of the Jefferies and Kotak conferences influence Cipla's stock valuation in the immediate weeks following the events?
Are there any pending regulatory approvals or pipeline developments that Cipla is expected to highlight to institutional investors during these meetings?


































